LEFELSIRAN
ID: ALA5314647
Max Phase: Preclinical
Associated Items:
ID: ALA5314647
Max Phase: Preclinical
Associated Items:
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Oligonucleotide | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: | Molecular Weight (Monoisotopic): | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
Source(1):